Santosh Mahil appointed CEO of Sekhmet Pharmaventures
Mahil to lead India-based API investment platform backed by PAG, CX Partners, and Samara Capital
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Servier India launches IDH1-targeted therapy Ivosidenib for AML and Cholangiocarcinoma
CDSCO approves Servier’s Ivosidenib for treatment of AML and Cholangiocarcinoma patients with IDH1 mutation
Atopic dermatitis market to reach $22.4 billion in 7MM by 2033, forecasts GlobalData
Projected market growth driven by expanded treatment options, novel therapies, and rising diagnosed prevalence across major global…
Alvotech and Dr Reddy’s Laboratories partner to develop biosimilar for Keytruda targeting global…
Collaboration aims to accelerate development and commercialisation of pembrolizumab biosimilar, expanding access to cancer…
Shorter immunotherapy duration for advanced melanoma shows comparable disease control in UK DANTE…
UK-led phase III trial reports similar disease control at 12 months versus two years of immunotherapy for inoperable late-stage…
PLUSS Advanced Technologies and Ecodome Logistics unite to build India’s greenest, most reliable…
Partnership aims to reduce vaccine spoilage, cut carbon emissions, and improve temperature control in pharma logistics across…
EyePoint’s Duravyu holds potential to become new treatment option for wAMD: GlobalData
Sustained-release implant Duravyu may reduce treatment burden in wet AMD patients while maintaining efficacy and durability
Gland Pharma receives USFDA approval for Angiotensin II Acetate injection
Gland Pharma secures 180-day exclusivity for Angiotensin II Acetate Injection following USFDA approval
IGI reports phase 1 results of ISB 2001 trispecific antibody in relapsed or refractory multiple…
TRIgnite-1 study shows 79 per cent response rate and no dose-limiting toxicities in early-stage trial of BCMA × CD38 × CD3…
Sun Pharma ends development of SCD-044 after phase 2 trials fail to meet primary endpoints
SCD-044 trials for psoriasis and atopic dermatitis show no major safety concerns
Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market
Company also signs licensing deal for exclusive rights to immuno-oncology therapies Botensilimab and Balstilimab in India and Sri…
India’s pharma startups raise $254.7 million in May 2025: Tracxn
Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round
TDB backs Nitika Pharmaceutical Specialties for domestic production of complex excipients
DST’s Technology Development Board extends financial support to Nagpur-based Nitika for manufacturing 14 advanced excipients under…
Indoco launches Ticagrelor film-coated tablets 90mg in the UK market
Indoco Remedies UK begins distribution of cardiovascular treatment via Clarity Pharma across the United Kingdom
Oliver Wyman appoints Dr Chirag Adatia as partner to lead health, life sciences in India
Dr Adatia to support Oliver Wyman’s healthcare and investor-focused strategy in India with cross-sector experience and digital…
Cipla appoints Prabhakaran Nair as Global Chief Manufacturing Officer
Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance
What US FDA’s new surprise foreign inspections plan means for India
Pharma companies exporting to the US should now rightly be on guard and start preparing for the inevitable “knock on the factory…
Zydus secures tentative USFDA approval for Rifaximin Tablets 550 mg
The tablets, used for treating IBS-D in adults, will be manufactured at the company’s SEZ II facility in Ahmedabad
CAR-T therapies need to overcome current limitations to unlock promising treatment possibilities for…
While CAR-Ts are transforming blood cancer treatment, their struggle in solid tumors highlights the urgent need for innovation in…
Pharma and medtech marketing: Navigating the imminent disclosure deadline
Kunal Gupta, Partner, White-Collar Crime Practice and Sahil Bansal, Counsel - White-Collar Crime Practice, Trilegal stress that…